Repository logo
 
Publication

Is Grace Risk Score the Holy Grail in Risk Stratification or Can We Improve it Even Further with Additional Biomarkers?

dc.contributor.authorTimóteo, AT
dc.date.accessioned2021-07-16T14:15:16Z
dc.date.available2021-07-16T14:15:16Z
dc.date.issued2020
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationArq Bras Cardiol. 2020 Apr;114(4):673-674.pt_PT
dc.identifier.doi10.36660/abc.20200171pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/3777
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSociedade Brasileira de Cardiologiapt_PT
dc.subjectBiomarkerspt_PT
dc.subjectHumanspt_PT
dc.subjectNatriuretic Peptide, Brainpt_PT
dc.subjectPeptide Fragmentspt_PT
dc.subjectPrognosispt_PT
dc.subjectRisk Assessmentpt_PT
dc.subjectAcute Coronary Syndromept_PT
dc.subjectHSM CARpt_PT
dc.titleIs Grace Risk Score the Holy Grail in Risk Stratification or Can We Improve it Even Further with Additional Biomarkers?pt_PT
dc.typeother
dspace.entity.typePublication
oaire.citation.endPage674pt_PT
oaire.citation.issue4pt_PT
oaire.citation.startPage673pt_PT
oaire.citation.titleArquivos Brasileiros de Cardiologiapt_PT
oaire.citation.volume114pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typeotherpt_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Arq Bras Cardiol 2020.pdf
Size:
145.88 KB
Format:
Adobe Portable Document Format

Collections